Published in Cardiovascular Business Week, August 9th, 2005
ev3's net sales in the second quarter of 2005 were $31.5 million, an increase of 53% versus net sales of $20.6 million in the second quarter of 2004, and an increase of 14% compared to net sales of $27.7 million in the first quarter of 2005. This growth was generated internally and reflected net sales growth in each of ev3's reportable business segments and geographic markets.
By segment, ev3's second quarter net sales of cardio peripheral products were $19.2 million, representing an increase of 58% versus the year-ago...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.